Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000040786 | SCV000064477 | benign | not specified | 2017-11-22 | criteria provided, single submitter | clinical testing | p.Asn28078Ser in exon 287 of TTN: This variant is not expected to have clinical significance because it has been identified in 0.6% (153/24006) of African chrom osomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute. org; dbSNP rs72648245). BA1 |
Eurofins Ntd Llc |
RCV000040786 | SCV000228678 | likely benign | not specified | 2014-09-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000714118 | SCV000237760 | benign | not provided | 2020-05-22 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001082069 | SCV000286912 | benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000249101 | SCV000318787 | likely benign | Cardiovascular phenotype | 2013-07-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000714118 | SCV000844793 | likely benign | not provided | 2017-10-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000768864 | SCV000900237 | benign | Cardiomyopathy | 2016-08-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839725 | SCV002102188 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2J | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839726 | SCV002102189 | benign | Myopathy, myofibrillar, 9, with early respiratory failure | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839727 | SCV002102190 | benign | Early-onset myopathy with fatal cardiomyopathy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001839724 | SCV002102191 | benign | Tibial muscular dystrophy | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000040786 | SCV004038620 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004541192 | SCV004759851 | likely benign | TTN-related disorder | 2019-12-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000714118 | SCV001926677 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000714118 | SCV001973877 | likely benign | not provided | no assertion criteria provided | clinical testing |